Search results
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 1 day agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 1 day agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 12 hours agovaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and older,...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 23 hours agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 1 day agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 5 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...